1 |
Ambrisentan |
Ambrisentan |
1件: D07077 D07077 💬 |
EDNRA 1件: EDNRA 💬 |
Calcium signaling pathway 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 7件: 51, 84, 85, 86, 88, 210, 211 💬 |
2 |
Ambrisentan - high dose |
Ambrisentan |
1件: D07077 D07077 💬 |
EDNRA 1件: EDNRA 💬 |
Calcium signaling pathway 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 1件: 86 💬 |
3 |
Ambrisentan - low dose |
Ambrisentan |
1件: D07077 D07077 💬 |
EDNRA 1件: EDNRA 💬 |
Calcium signaling pathway 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 1件: 86 💬 |
4 |
Ambrisentan 5 mg |
Ambrisentan |
1件: D07077 D07077 💬 |
EDNRA 1件: EDNRA 💬 |
Calcium signaling pathway 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
088 1件: 88 💬 |
5 |
Ambrisentan 5 mg film-coated tablets |
Ambrisentan |
1件: D07077 D07077 💬 |
EDNRA 1件: EDNRA 💬 |
Calcium signaling pathway 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 1件: 86 💬 |
6 |
Ambrisentan 5mg film-coated tablets [marketed product] |
Ambrisentan |
1件: D07077 D07077 💬 |
EDNRA 1件: EDNRA 💬 |
Calcium signaling pathway 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 1件: 86 💬 |
7 |
Ambrisentan plus spironolactone |
Ambrisentan |
2件: D00443 D00443, D07077 D07077 💬 |
EDNRA 2件: EDNRA, NR3C2 💬 |
Aldosterone-regulated sodium reabsorption 8件: Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 1件: 86 💬 |
8 |
Ambrisentan tablet |
Ambrisentan |
1件: D07077 D07077 💬 |
EDNRA 1件: EDNRA 💬 |
Calcium signaling pathway 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 1件: 86 💬 |
9 |
Bosentan, ambrisentan |
Ambrisentan |
3件: D01227 D01227, D07077 D07077, D07538 D07538 💬 |
EDNRA 2件: EDNRA, EDNRB 💬 |
Calcium signaling pathway 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 1件: 86 💬 |
10 |
Tadalafil and ambrisentan upfront combination therapy |
Ambrisentan |
2件: D02008 D02008, D07077 D07077 💬 |
EDNRA 2件: EDNRA, PDE5A 💬 |
Calcium signaling pathway 9件: Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 2件: 51, 86 💬 |
11 |
Volibris® (ambrisentan) |
Ambrisentan |
1件: D07077 D07077 💬 |
EDNRA 1件: EDNRA 💬 |
Calcium signaling pathway 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 1件: 86 💬 |